Triple-negative breast cancer (TNBC) is a special type of breast cancer that is characterized by the progesterone receptor (PR), estrogen receptor (ER), and human epidermal growth factor receptor 2 (HER2), all of which are negative (Parise and Caggiano, 2017; Liao et al., 2018). The gene discussed is ERBB2; the disease is breast cancer.